SEC Halts Nasdaq’s Bitcoin Options After CME Challenge

The SEC paused Nasdaq's QBTC Bitcoin options after CME Group challenged the regulator's jurisdiction, arguing the product falls under CFTC authority.

This move follows a challenge by CME Group against the regulator’s authority, with the exchange arguing that the product falls under the exclusive jurisdiction of the Commodity Futures Trading Commission (CFTC), rather than the SEC.

The administrative stay puts the project on hold while the full SEC membership reviews the objection. Until a final decision is reached, Nasdaq will be unable to bring the product to market.

CME Questions SEC Authority

At the heart of the dispute is the question of which regulator should oversee options tied to the price of BTC.

CME contends that Bitcoin is a commodity, not a security, meaning derivatives based on its spot price should be regulated by the CFTC. The company argues that the SEC cannot use administrative approval to authorize the listing of a product that is inherently a commodity derivative.

In its petition, CME warns that such a decision would set a precedent, potentially allowing SEC-regulated exchanges to offer derivatives on other commodities without falling under the CFTC’s oversight regime.

The company maintains that using regulatory exemptions cannot change the competent supervisory authority for a specific financial instrument.

What This Means for QBTC

The SEC approval granted in May anticipated that the product would become available once the necessary exemptions were obtained from the CFTC. This would have allowed Nasdaq and the Options Clearing Corporation to offer the options through securities market infrastructure.

However, that entire process has been paused following the formal objection.

If the Commission accepts CME’s arguments, Nasdaq might be forced to completely redesign the product’s structure. One option would be for the exchange to register its platform under CFTC rules, which apply to futures and swap markets. Alternatively, the contracts could be modified to be based on a security—such as a spot BTC ETF—rather than directly on the price of Bitcoin itself.

Trading for QBTC remains frozen for an indefinite period pending the SEC’s ruling.

Decision Could Have Wider Implications

The dispute extends beyond a single product, touching on the division of power between the two primary U.S. financial regulators.

Bitcoin has been consistently treated as a commodity in recent years, and CME already operates regulated markets for BTC futures and options under CFTC supervision. The company argues that allowing a competing product through an SEC-regulated regime would create disparate regulatory standards for similar financial instruments.

For its part, Nasdaq had planned to utilize the CME CF Bitcoin Reference Rate for both the underlying index and the final cash settlement of the contracts.

The SEC will accept public comments on the case until August 24. Following this period, the commission must decide whether to uphold its initial approval, overturn it, or demand structural changes to the product.

The outcome of this dispute will likely resonate far beyond QBTC, as it could define the rules for listing future crypto derivatives in the U.S. and clarify the boundary between SEC and CFTC jurisdictions.